On ECHEMI
Home > Drugs > Prostatic hyperplasia
Prostatic hyperplasia
Prostatic hyperplasia, formerly known as prostatic hypertrophy, is a common disease in middle-aged and elderly men. It is a benign lesion of the prostate. The cause of its hyperplasia is closely related to changes in male hormones and testicles. At the same time, excessive sexual activity, masturbation, interrupted sexual intercourse and irritating foods can all cause excessive congestion of the testicles and prostate. Repeated excessive congestion can easily cause the testicles to atrophy, and the prostate will easily hypertrophy and proliferate over time. Its common symptoms are frequent urination, urgency (inability to hold back urine), incomplete urination (feeling of incomplete urination), intermittent urination, urinary incontinence, etc. According to foreign statistics, about half of men over 40 years old suffer from benign prostatic hyperplasia, and patients over 80 years old can reach 80%. According to clinical evidence, more than 60% of men over 50 years old have enlarged prostates.
Related Drugs
Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of urine stream, difficulty urinating, increased nocturia, feeling of incomplete urination, etc.
Manufacturer:

Yangzhou Ilyang Pharm. Co., Ltd.

Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of the urine stream, difficulty urinating, increased nocturia, feeling of incomplete urination, etc.
Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, and can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of the urine stream, difficulty urinating, increased nocturia, and a feeling of incomplete urination.
Manufacturer:

Shijiazhuang Kedi Pharmaceutical Co., Ltd.

Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of urine stream, difficulty urinating, increased nocturia, feeling of incomplete urination, etc.
Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, and can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of the urine stream, difficulty urinating, increased nocturia, and a feeling of incomplete urination.
Terazosin Hydrochloride Tablets
Indication: 1. Used to treat hypertension, and can be used alone or in combination with other antihypertensive drugs. 2. Used to improve urination symptoms in patients with benign prostatic hyperplasia, such as frequent urination, urgency, thinning of the urine stream, difficulty urinating, increased nocturia, and a feeling of incomplete urination.
Qianlenin Capsules
Manufacturer:

Arura Tibetan MEDICINE Co., Ltd.

Doxazosin Mesylate Tablets
Indication: For patients with primary mild to moderate hypertension whose blood pressure is difficult to control with medication alone, it can be used in combination with diuretics, beta-blockers, calcium antagonists or angiotensin-converting enzyme inhibitors (ACEⅠ).
Manufacturer:

Hangzhou Conba Pharmaceutical Co., Ltd.

Doxazosin Mesylate Tablets
Indication: Essential hypertension; benign prostatic hyperplasia.
Manufacturer:

Kangmei Pharmaceutical Co., Ltd.

Prostate pulse therapy device
Indication: Adjuvant treatment of non-bacterial chronic prostatitis and prostatic hyperplasia.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.